Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Neoplasms malignant site unspecified NEC
ADR ID BADD_A03009
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
Description Not Available
MedDRA Code 10029105
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00998Gallium cation--
BADD_D01008Gefitinib0.016957%
BADD_D01009Gemcitabine0.000895%
BADD_D01010Gemcitabine hydrochloride--
BADD_D01022Gliclazide--
BADD_D01035Golimumab--
BADD_D01038Goserelin0.014682%
BADD_D01040Granisetron0.006196%
BADD_D01083Hydrochlorothiazide0.000076%
BADD_D01086Hydrocortisone0.000069%
BADD_D01095Hydrogen iodide--
BADD_D01096Hydromorphone--
BADD_D01103Hydroxychloroquine--
BADD_D01110Hydroxyurea0.003302%
BADD_D01119Ibrutinib0.003358%
BADD_D01130Idelalisib0.000504%
BADD_D01133Ifosfamide0.000392%
BADD_D01136Imatinib0.038033%
BADD_D01142Imiquimod--
BADD_D01149Indapamide0.000377%
BADD_D01156Indomethacin--
BADD_D01157Infliximab--
BADD_D01158Ingenol mebutate--
BADD_D01163Insulin glargine--
BADD_D01179Ioflupane i-123--
BADD_D01195Irinotecan0.002485%
BADD_D01196Irinotecan hydrochloride--
BADD_D01197Iron--
BADD_D01223Ixazomib0.001679%
BADD_D01230Ketoconazole0.000099%
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 14 Pages